Dr. Teralyn

Dr. Teralyn Dr. Teralyn Sell, PhD. Psychology-led, biology-informed authority on psychiatric medication decision-making and deprescribing. PhD on a mission! I’m really o.k.

Focused on judgment, informed consent, and long-term outcomes, without urgency, shortcuts, or reassurance-based care. You’ve Tried Everything & You Still Feel Like Sh!t

Sometimes I get told that I’m pretty much the last stop that my clients make. They come to me exhausted, disappointed, frustrated and basically tapped out. Western medicine has all but failed them and they are left feeling ‘blah’

from a bunch of prescriptions and no light at the end of the tunnel. with being the last stop because you always find what you’re looking for in the last place you look. Let’s get you feeling better, Naturally! Whether I’m the first place you’ve stopped at or the last place you will ever need I am completely stoked to help you not only feel better faster, but also really uncover why you felt that way in the first place. While we can’t change what you have endured in the past, we can work together to better comprehend and settle the challenges you face today. It’s time to stop holding back on your life and start moving forward, naturally!

05/28/2026

IBS and antidepressants are so commonly prescribed.

05/27/2026

The hard part was at the tome I didn't think I was emotionally blunted because I could feel a ton of negative emotions. Some people can't feel any emotions. But those negative emotions made me not care about connection. what are your experiences.

05/26/2026

Why do people share negative experiences with psych meds?
Because absence of harm in your awareness is not the same as absence of risk.
If you didn’t know a side effect was possible, you didn’t consent to it.
That’s not anti-medication. That’s basic decision integrity.
I’m not against personal choice.
I’m against uninformed choice dressed up as care.
And professionals—this matters.
Defensiveness around medication doesn’t protect patients.
It protects the system that failed to inform them.
If the full risk profile isn’t part of the conversation,
you’re not practicing informed consent. You’re bypassing it.
“Live, laugh, Lexapro” isn’t harmless branding.
It’s what minimizing risk looks like in real time.

05/25/2026

My story has evolved in so many ways. My healing in total took about 2 years after SSRI use. I continue to have autoimmune and metabolic issues but I have come to terms with those. Because I am healthy I will use my voice to be unstoppable

I’m watching this come out of the American Psychiatric Association 2026 meeting, and honestly—it feels familiar.We’ve be...
05/25/2026

I’m watching this come out of the American Psychiatric Association 2026 meeting, and honestly—it feels familiar.

We’ve been here before.

In 2022, the 2022 serotonin hypothesis meta-analysis challenged the chemical imbalance theory, and suddenly it was, “we never said that.”

Now it’s the same pattern, just a different issue.

I’m hearing psychiatrists say they fear withdrawal.
That they regret not deprescribing sooner.
That we don’t actually have good data on what happens when people stop these medications.

And at the same time—
the drugs are still framed as safe, the model stays intact, and nothing fundamentally shifts.

That’s not a small inconsistency.
That’s the system protecting itself.

And now we’re talking about a “therapy-first” model…

But where are the therapists in that conversation?
Where are the voices actually working with patients through the emotional, behavioral, and identity fallout of these decisions?

You can’t build a therapy-first system
without the people who actually do the therapy.

That’s not reform.
That’s optics.

So again, the language adjusts just enough to absorb the criticism—
without changing the structure underneath it.

And patients are left making long-term decisions inside that.

That’s the part I can’t ignore.

withdrawal therapyfirst mentalhealthcare healthpolicy medicalethics evidencebased psychology brainhealth overmedicalization apa

I’m watching this come out of the American Psychiatric Association 2026 meeting, and honestly—it feels familiar.We’ve be...
05/25/2026

I’m watching this come out of the American Psychiatric Association 2026 meeting, and honestly—it feels familiar.

We’ve been here before.

In 2022, the 2022 serotonin hypothesis meta-analysis challenged the chemical imbalance theory, and suddenly it was, “we never said that.”

Now it’s the same pattern, just a different issue.

I’m hearing psychiatrists say they fear withdrawal.
That they regret not deprescribing sooner.
That we don’t actually have good data on what happens when people stop these medications.

And at the same time—
the drugs are still framed as safe, the model stays intact, and nothing fundamentally shifts.

That’s not a small inconsistency.
That’s the system protecting itself.

And now we’re talking about a “therapy-first” model…

But where are the therapists in that conversation?
Where are the voices actually working with patients through the emotional, behavioral, and identity fallout of these decisions?

You can’t build a therapy-first system
without the people who actually do the therapy.

That’s not reform.
That’s optics.

So again, the language adjusts just enough to absorb the criticism—
without changing the structure underneath it.

And patients are left making long-term decisions inside that.

That’s the part I can’t ignore.

I’m watching this come out of the most recent American Psychiatric Association 2026 meeting. Here are their direct quote...
05/25/2026

I’m watching this come out of the most recent American Psychiatric Association 2026 meeting. Here are their direct quotes, please pay attention.

We’ve been here before. The denial, the dismissing of the patients lived experiences.

In 2022, the 2022 serotonin hypothesis meta-analysis challenged the chemical imbalance theory, and suddenly it was, “we never said that.”

Now it’s the same pattern, just a different issue. Overprescribing and deprescribing.

I’m hearing psychiatrists say they fear withdrawal.
That they regret not deprescribing sooner.
That we don’t actually have good data on what happens when people stop these medications.

And at the same time,
the drugs are still framed as safe, the model stays intact, and nothing fundamentally shifts at all.

That’s not a small inconsistency.
That’s the system protecting itself.

And now we’re talking about a “therapy-first” model…

But where are the therapists in that conversation?
Where are the voices actually working with patients through the emotional, behavioral, and identity fallout of these decisions?

You can’t build a therapy-first system
without the people who actually do the therapy.

That’s not reform.
That’s optics.

So again, the language adjusts just enough to absorb the criticism
without changing the structure underneath it.

And patients are left making long-term decisions inside that.

That’s the part I can’t ignore.

05/24/2026

So many manipulative things were said from providers, friends when I would lodge a complaint about how I felt. Most of it was blamed on my husband. I quickly learned to say nothing at all and figure things out on my own. What things were you told?

05/24/2026

If I would have been told what antidepressants could take from me, I would have said no. But I wasn't told. Instead I was forced to navigate it on my own. I lost 6 years of memories, I was disconnected to others, I couldn't feel pleasure, my sexuality was stolen. My health took a toll at one point I was on 2 other meds for those reasons. Antidepressants were prescribed to be as a preventative for PPD and suddenly I was a forever patient with a chemical imbalance.

Address

Menasha, WI

Website

Alerts

Be the first to know and let us send you an email when Dr. Teralyn posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dr. Teralyn:

Shortcuts

Share